|
1
|
Ajani J, D’Amico TA, Hayman JA, Meropol NJ
and Minsky B; National Comprehensive Cancer Network. Gastric
cancer. Clinical practice guidelines in oncology. J Natl Compr
Cancer Netw. 1:28–39. 2003.
|
|
2
|
Chen XM, Chen GY, Wang ZR, Zhu FS, Wang XL
and Zhang X: Detection of micrometastasis of gastric carcinoma in
peripheral blood circulation. World J Gastroenterol. 10:804–808.
2004.PubMed/NCBI
|
|
3
|
Rivera F, Vega-Villegas ME and Lopez-Brea
MF: Chemotherapy of advanced gastric cancer. Cancer Treat Rev.
33:315–324. 2007. View Article : Google Scholar
|
|
4
|
Falcone A: Future strategies and adjuvant
treatment of gastric cancer. Ann Oncol. 14:ii45–ii47. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li W, Yu CP, Xia JT, et al: Sphingosine
kinase 1 is associated with gastric cancer progression and poor
survival of patients. Clin Cancer Res. 15:1393–1399. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maceyka M, Payne SG, Milstien S and
Spiegel S: Sphingosine kinase, sphingosine-1-phosphate, and
apoptosis. Biochim Biophys Acta. 1585:193–201. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cuvillier O, Pirianov G, Kleuser B, et al:
Suppression of ceramide-mediated programmed cell death by
sphingosine-1-phosphate. Nature. 381:800–803. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hannun YA and Luberto C: Ceramide in the
eukaryotic stress response. Trends Cell Biol. 10:73–80. 2000.
View Article : Google Scholar
|
|
9
|
Kolesnick R and Hannun YA: Ceramide and
apoptosis. Trends Biochem Sci. 24:224–225. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spiegel S and Milstien S:
Sphingosine-1-phosphate: signaling inside and out. FEBS Lett.
476:55–57. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pyne S and Pyne NJ: Sphingosine
1-phosphate signalling in mammalian cells. Biochem J. 349:385–402.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hait NC, Oskeritzian CA, Paugh SW,
Milstien S and Spiegel S: Sphingosine kinases, sphingosine
1-phosphate, apoptosis and diseases. Biochim Biophys Acta.
1758:2016–2026. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Olivera A, Kohama T, Edsall L, et al:
Sphingosine kinase expression increases intracellular
sphingosine-1-phosphate and promotes cell growth and survival. J
Cell Biol. 147:545–558. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Edsall LC, Cuvillier O, Twitty S, Spiegel
S and Milstien S: Sphingosine kinase expression regulates apoptosis
and caspase activation in PC12 cells. J Neurochem. 76:1573–1584.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bonhoure E, Pchejetski D, Aouali N, et al:
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid
leukemia cells by targeting sphingosine kinase-1. Leukemia.
20:95–102. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pchejetski D, Golzio M, Bonhoure E, et al:
Sphingosine kinase-1 as a chemotherapy sensor in prostate
adenocarcinoma cell and mouse models. Cancer Res. 65:11667–11675.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Manning BD and Cantley LC: AKT/PKB
signaling: navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kapitonov D, Allegood JC, Mitchell C, et
al: Targeting sphingosine kinase 1 inhibits Akt signaling, induces
apoptosis, and suppresses growth of human glioblastoma cells and
xenografts. Cancer Res. 69:6915–6923. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nemoto S, Nakamura M, Osawa Y, et al:
Sphingosine kinase isoforms regulate oxaliplatin sensitivity of
human colon cancer cells through ceramide accumulation and Akt
activation. J Biol Chem. 284:10422–10432. 2009. View Article : Google Scholar
|
|
20
|
Radeff-Huang J, Seasholtz TM, Chang JW,
Smith JM, Walsh CT and Brown JH: Tumor necrosis
factor-alpha-stimulated cell proliferation is mediated through
sphingosine kinase-dependent Akt activation and cyclin D
expression. J Biol Chem. 282:863–870. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tran H, Brunet A, Griffith EC and
Greenberg ME: The many forks in FOXO’s road. Sci STKE.
2003:RE52003.
|
|
22
|
Hahn WC, Dessain SK, Brooks MW, et al:
Enumeration of the simian virus 40 early region elements necessary
for human cell transformation. Mol Cell Biol. 22:2111–2123. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li J, Zhang N, Song LB, et al: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
25
|
Huang H and Tindall DJ: Dynamic FoxO
transcription factors. J Cell Sci. 120:2479–2487. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Accili D and Arden KC: FoxOs at the
crossroads of cellular metabolism, differentiation, and
transformation. Cell. 117:421–426. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barthel A, Schmoll D and Unterman TG: FoxO
proteins in insulin action and metabolism. Trends Endocrinol Metab.
16:183–189. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Biggs WH III, Meisenhelder J, Hunter T,
Cavenee WK and Arden KC: Protein kinase B/Akt-mediated
phosphorylation promotes nuclear exclusion of the winged helix
transcription factor FKHR1. Proc Natl Acad Sci USA. 96:7421–7426.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brunet A, Bonni A, Zigmond MJ, et al: Akt
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kops GJ, de Ruiter ND, De Vries-Smits AM,
Powell DR, Bos JL and Burgering BM: Direct control of the Forkhead
transcription factor AFX by protein kinase B. Nature. 398:630–634.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sunters A, Fernandez de Mattos S, Stahl M,
et al: FoxO3a transcriptional regulation of Bim controls apoptosis
in paclitaxel-treated breast cancer cell lines. J Biol Chem.
278:49795–49805. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dijkers PF, Medema RH, Lammers JW,
Koenderman L and Coffer PJ: Expression of the pro-apoptotic Bcl-2
family member Bim is regulated by the forkhead transcription factor
FKHR-L1. Curr Biol. 10:1201–1204. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stahl M, Dijkers PF, Kops GJ, et al: The
forkhead transcription factor FoxO regulates transcription of
p27Kip1 and Bim in response to IL-2. J Immunol. 168:5024–5031.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gilley J, Coffer PJ and Ham J: FOXO
transcription factors directly activate bim gene expression and
promote apoptosis in sympathetic neurons. J Cell Biol. 162:613–622.
2003. View Article : Google Scholar : PubMed/NCBI
|
